drugset / Trial / NCT00813241

A Pilot Open-Label Crossover Bioavailability Study of Celecoxib in Healthy Volunteers

NCT00813241

Phase 1 Completed 16 enrolled Viatris Inc.
RandomizedCrossoverOpen-labelOther

Summary

A pharmacokinetic study in healthy volunteers to determine the relative bioavailability of three formulations of celecoxib to the approved formulation.

Timeline

Start
2009-01
Primary completion
2009-03
Completion
2009-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Celecoxib Other / unclassified 150 mg Oral
Comparator Celecoxib Other / unclassified 200 mg Oral

Indications

No indication recorded.